 Juan Idrovo
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 8 | 2023 | 237 | 3.540 |
Why?
| | Liver Diseases | 2 | 2021 | 254 | 1.210 |
Why?
| | Reperfusion Injury | 3 | 2015 | 254 | 1.080 |
Why?
| | 4-Butyrolactone | 2 | 2015 | 19 | 0.910 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2015 | 10 | 0.900 |
Why?
| | Wound Healing | 2 | 2016 | 258 | 0.860 |
Why?
| | Inflammation | 3 | 2020 | 2485 | 0.840 |
Why?
| | Caspases | 1 | 2023 | 245 | 0.800 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 5 | 0.720 |
Why?
| | Severe Acute Respiratory Syndrome | 1 | 2020 | 13 | 0.710 |
Why?
| | Alcoholic Intoxication | 1 | 2019 | 62 | 0.640 |
Why?
| | Liver | 3 | 2023 | 1634 | 0.620 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 342 | 0.620 |
Why?
| | Coronavirus Infections | 2 | 2020 | 334 | 0.610 |
Why?
| | Betacoronavirus | 2 | 2020 | 253 | 0.600 |
Why?
| | Transcriptome | 1 | 2023 | 728 | 0.590 |
Why?
| | Intestines | 2 | 2021 | 326 | 0.550 |
Why?
| | Hepatic Insufficiency | 1 | 2015 | 4 | 0.510 |
Why?
| | Adrenomedullin | 1 | 2015 | 5 | 0.500 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2012 | 43 | 0.490 |
Why?
| | Ribonucleotides | 1 | 2015 | 24 | 0.490 |
Why?
| | Lipogenesis | 1 | 2015 | 57 | 0.490 |
Why?
| | Complement Factor H | 1 | 2015 | 60 | 0.470 |
Why?
| | Skin | 2 | 2016 | 659 | 0.450 |
Why?
| | Shock, Hemorrhagic | 1 | 2016 | 193 | 0.440 |
Why?
| | Pandemics | 2 | 2020 | 1325 | 0.420 |
Why?
| | RNA-Binding Proteins | 1 | 2016 | 344 | 0.420 |
Why?
| | Mice | 9 | 2023 | 14936 | 0.420 |
Why?
| | Animals | 14 | 2023 | 31839 | 0.410 |
Why?
| | Ribonucleosides | 1 | 2012 | 5 | 0.400 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 752 | 0.400 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2011 | 33 | 0.390 |
Why?
| | Renal Circulation | 1 | 2011 | 53 | 0.390 |
Why?
| | Renal Artery | 1 | 2011 | 25 | 0.390 |
Why?
| | Carnitine | 1 | 2012 | 62 | 0.390 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 451 | 0.380 |
Why?
| | Acute Lung Injury | 1 | 2015 | 300 | 0.380 |
Why?
| | Arterial Occlusive Diseases | 1 | 2011 | 73 | 0.380 |
Why?
| | Energy Metabolism | 2 | 2012 | 724 | 0.350 |
Why?
| | Sepsis | 1 | 2015 | 508 | 0.330 |
Why?
| | Rats, Sprague-Dawley | 4 | 2015 | 2211 | 0.310 |
Why?
| | Kidney | 2 | 2012 | 1184 | 0.310 |
Why?
| | Aspartate Aminotransferases | 2 | 2021 | 86 | 0.300 |
Why?
| | Recovery of Function | 1 | 2012 | 572 | 0.300 |
Why?
| | Alanine Transaminase | 2 | 2021 | 141 | 0.300 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2020 | 1134 | 0.280 |
Why?
| | Age Factors | 3 | 2022 | 2891 | 0.270 |
Why?
| | Kidney Transplantation | 1 | 2011 | 542 | 0.260 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 638 | 0.260 |
Why?
| | Intestinal Mucosa | 3 | 2021 | 530 | 0.250 |
Why?
| | Cough | 3 | 2020 | 107 | 0.250 |
Why?
| | Rats | 4 | 2015 | 4963 | 0.250 |
Why?
| | Fever | 3 | 2020 | 279 | 0.240 |
Why?
| | Dysbiosis | 2 | 2023 | 146 | 0.230 |
Why?
| | Interleukin-6 | 2 | 2020 | 676 | 0.230 |
Why?
| | Neovascularization, Physiologic | 2 | 2016 | 173 | 0.230 |
Why?
| | Peroxidase | 2 | 2015 | 157 | 0.220 |
Why?
| | Caspase 9 | 1 | 2023 | 48 | 0.220 |
Why?
| | Fluorouracil | 1 | 2023 | 152 | 0.210 |
Why?
| | Travel | 2 | 2020 | 121 | 0.210 |
Why?
| | Caspase 3 | 1 | 2023 | 238 | 0.200 |
Why?
| | Delirium | 1 | 2023 | 66 | 0.200 |
Why?
| | Dyspnea | 2 | 2020 | 218 | 0.200 |
Why?
| | Tight Junctions | 1 | 2021 | 68 | 0.190 |
Why?
| | Malondialdehyde | 1 | 2021 | 28 | 0.190 |
Why?
| | Human papillomavirus 16 | 1 | 2021 | 25 | 0.190 |
Why?
| | Astrocytes | 1 | 2022 | 162 | 0.180 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 139 | 0.180 |
Why?
| | Chemokine CXCL1 | 1 | 2020 | 66 | 0.180 |
Why?
| | Papillomaviridae | 1 | 2021 | 102 | 0.180 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2021 | 77 | 0.180 |
Why?
| | Blood Cell Count | 1 | 2020 | 52 | 0.180 |
Why?
| | Resistin | 1 | 2019 | 12 | 0.170 |
Why?
| | Gastric Inhibitory Polypeptide | 1 | 2019 | 14 | 0.170 |
Why?
| | China | 1 | 2020 | 162 | 0.170 |
Why?
| | Adenosine Triphosphate | 2 | 2012 | 431 | 0.170 |
Why?
| | Ghrelin | 1 | 2019 | 33 | 0.170 |
Why?
| | Glutathione | 1 | 2021 | 300 | 0.170 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2019 | 83 | 0.160 |
Why?
| | Disease Models, Animal | 2 | 2021 | 3549 | 0.160 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 100 | 0.160 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 169 | 0.150 |
Why?
| | Interleukin-1beta | 1 | 2020 | 370 | 0.150 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 4719 | 0.150 |
Why?
| | Leptin | 1 | 2019 | 211 | 0.150 |
Why?
| | Models, Animal | 1 | 2019 | 346 | 0.150 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1153 | 0.150 |
Why?
| | Apoptosis | 2 | 2023 | 2371 | 0.140 |
Why?
| | Adenocarcinoma | 1 | 2023 | 801 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1523 | 0.140 |
Why?
| | Respiratory Tract Infections | 1 | 2020 | 321 | 0.140 |
Why?
| | Alcoholism | 1 | 2023 | 715 | 0.130 |
Why?
| | Microbiota | 1 | 2023 | 649 | 0.130 |
Why?
| | Male | 7 | 2020 | 55663 | 0.130 |
Why?
| | Lung | 2 | 2020 | 3593 | 0.130 |
Why?
| | Ethanol | 1 | 2019 | 548 | 0.120 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2015 | 107 | 0.120 |
Why?
| | Bacterial Load | 1 | 2015 | 58 | 0.120 |
Why?
| | Influenza, Human | 1 | 2020 | 546 | 0.120 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 94 | 0.120 |
Why?
| | Hospitalization | 2 | 2020 | 1754 | 0.120 |
Why?
| | Female | 6 | 2021 | 59581 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 502 | 0.120 |
Why?
| | Humans | 13 | 2023 | 114937 | 0.120 |
Why?
| | Aged | 5 | 2023 | 19122 | 0.110 |
Why?
| | Lymph Nodes | 1 | 2015 | 425 | 0.100 |
Why?
| | Spasm | 1 | 2011 | 19 | 0.100 |
Why?
| | Edema | 1 | 2012 | 119 | 0.100 |
Why?
| | Gallbladder Neoplasms | 1 | 2011 | 11 | 0.090 |
Why?
| | Ligands | 2 | 2023 | 565 | 0.090 |
Why?
| | Constriction, Pathologic | 1 | 2011 | 209 | 0.090 |
Why?
| | Leukocytes | 1 | 2012 | 277 | 0.090 |
Why?
| | Blood Glucose | 1 | 2019 | 1821 | 0.090 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2011 | 71 | 0.090 |
Why?
| | Blood Flow Velocity | 1 | 2011 | 387 | 0.090 |
Why?
| | Insulin | 1 | 2019 | 2079 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2015 | 9105 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1870 | 0.080 |
Why?
| | Neutrophils | 1 | 2015 | 1164 | 0.080 |
Why?
| | Living Donors | 1 | 2011 | 271 | 0.080 |
Why?
| | Fatty Acids | 1 | 2012 | 382 | 0.080 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 954 | 0.080 |
Why?
| | Signal Transduction | 1 | 2020 | 4525 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 8637 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1801 | 0.070 |
Why?
| | Biomarkers | 1 | 2015 | 3418 | 0.060 |
Why?
| | Glypicans | 1 | 2023 | 9 | 0.060 |
Why?
| | Body Surface Area | 1 | 2022 | 27 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 26 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 213 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 10 | 0.050 |
Why?
| | Colon | 1 | 2023 | 233 | 0.050 |
Why?
| | Permeability | 1 | 2021 | 148 | 0.050 |
Why?
| | Human papillomavirus 18 | 1 | 2021 | 14 | 0.050 |
Why?
| | Time Factors | 1 | 2011 | 6125 | 0.050 |
Why?
| | Infectious Disease Incubation Period | 1 | 2020 | 4 | 0.050 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 50 | 0.050 |
Why?
| | Influenza B virus | 1 | 2020 | 34 | 0.050 |
Why?
| | Pharyngitis | 1 | 2020 | 24 | 0.040 |
Why?
| | Influenza A virus | 1 | 2020 | 90 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 270 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1440 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 642 | 0.040 |
Why?
| | Hippocampus | 1 | 2022 | 696 | 0.040 |
Why?
| | Papillomavirus Infections | 1 | 2021 | 262 | 0.040 |
Why?
| | Survival Analysis | 1 | 2020 | 1220 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 728 | 0.040 |
Why?
| | Homeostasis | 1 | 2020 | 576 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1635 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 2725 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2199 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12544 | 0.030 |
Why?
| | Adult | 2 | 2021 | 30608 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 983 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 1843 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2020 | 802 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3344 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2542 | 0.030 |
Why?
| | Middle Aged | 2 | 2022 | 26806 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2326 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1621 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6364 | 0.010 |
Why?
|
|
Idrovo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|